Enzyme Finance

**Credilabs** and **Turtle** have successfully implemented a **tokenized credit card receivables financing structure** on the Enzyme protocol as part of a Visa program. **Key Details:** - The implementation represents a real-world application of tokenized finance infrastructure - Built on Enzyme's asset management protocol on Ethereum - Part of Visa's broader blockchain and tokenization initiatives This deployment demonstrates how traditional financial instruments like credit card receivables can be brought on-chain through tokenization, enabling more efficient and transparent financing structures. Learn more at [enzyme.finance](http://enzyme.finance)

**The Reality of On-Chain Private Credit** Private credit represents a massive $6 trillion market that remains largely dependent on traditional spreadsheets and manual processes. The industry is exploring how blockchain infrastructure could modernize these operations. **Key Points:** - Private credit markets currently operate through legacy systems - On-chain rails present potential efficiency improvements - Implementation details reveal the gap between discussion and execution - Industry experts are examining practical applications beyond theoretical benefits The conversation around tokenizing private credit continues to evolve from conceptual frameworks to real-world deployment considerations.

**Enzyme has officially joined the Canton Foundation**, marking a significant step in expanding its infrastructure to regulated finance networks. **Key developments:** - Enzyme becomes a member of the Canton Foundation - Plans to bring **Onyx and Myso** natively to Canton Network in Q3 2026 - Aims to provide vault infrastructure for Canton's privacy-first, regulated finance rails Canton Network focuses on institutional-grade blockchain infrastructure with privacy features designed for regulated financial institutions. Enzyme's integration will bring its decentralized asset management capabilities to this environment. The move represents Enzyme's strategic expansion beyond Ethereum into networks serving traditional finance institutions seeking blockchain solutions.

A leading lending protocol achieved a **$224,000 operational subsidy** from a $1M treasury position without liquidating any tokens. **Key Strategy Details:** - Utilized [Enzyme Myso](https://enzyme.finance/products/myso) for systematic covered call options - Generated **24% annual yield** - Zero liquidation risk throughout the process **How It Works:** The protocol integrated Enzyme Myso to create and manage onchain options directly within their treasury management system. This approach allowed them to earn premium income while maintaining full exposure to their underlying assets. Enzyme Myso has distributed over **$2M in premiums** to date, offering both automated and OTC options trading capabilities for protocols and their users.

Binance delisted MLN without prior notice to Enzyme, providing no specific reason for the decision. The company clarified the delisting is unrelated to operational concerns. **Key Points:** - MLN remains listed on several major centralized exchanges - Enzyme reports strongest performance in its 9-year history - Over 10 asset managers adopted Onyx infrastructure since Q4 2025 launch - Onyx AUT now exceeds historical protocol with revenues at all-time highs **Recent Achievements:** - April 2026 marked strongest month in company history - New features: cross-chain deposits, synchronous subscriptions, NAV automation - Integrations with Octav and 1Token completed - Upcoming extensions to Canton and Rayls networks Enzyme's tokenized fund infrastructure powers hedge funds, gold trackers, private credit, and money market funds. The protocol continues expanding despite challenging market conditions.

**Enzyme Onyx** addresses different protocol needs across three key stages: - **Pre-TGE**: Early participation incentives to build community - **Post-TGE**: Strengthen Total Value Locked (TVL) after token launch - **Mature stage**: Manage liquidity across multiple assets including stablecoins and liquid staking tokens The platform provides structured, on-chain strategies that protocols can adopt when timing is right for their development phase. Each stage requires different tooling approaches, but most protocols eventually need comprehensive on-chain financial infrastructure. [Explore Onyx](https://enzyme.finance/products/onyx?utm_source=x&utm_medium=organic&utm_content=post)

**Multi-chain complexity solved**: As investment products expand across different blockchains, reporting becomes increasingly complex for asset managers. **Automated data sourcing**: Chainlink's CRE (Crypto Reporting Engine) automatically pulls and verifies NAV and performance data from: - On-chain sources - Centralized finance platforms - Traditional financial systems **Pain point addressed**: The solution eliminates manual reporting work that previously required tracking assets across multiple chains and platforms. **Verification built-in**: All data is automatically verified, reducing errors and ensuring accuracy for compliance and investor reporting.

Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)

Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)

Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)